Aleta Biotherapeutics Patents – Insights & Stats (Updated 2023)

Aleta Biotherapeutics has a total of 119 patents globally, out of which 8 have been granted. Of these 119 patents, more than 63% patents are active. The United States is where Aleta Biotherapeutics has filed the maximum number of patents, followed by Japan and Mexico. Parallelly, the United States seems to be the main focused R&D center of Aleta Biotherapeutics and is also the origin country of the firm.

Aleta Biotherapeutics was founded in the year 2015 by Paul D. Rennert and Roy Lobb. The company focuses on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be targeted.

Do read about some of the most popular patents of Aleta Biotherapeutics which have been covered by us in this article and also you can find Aleta Biotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Aleta Biotherapeutics patent portfolio.

How many patents does Aleta Biotherapeutics have?

Aleta Biotherapeutics has a total of 119 patents globally. These patents belong to 11 unique patent families. Out of 119 patents, 76 patents are active.

How Many Patents did Aleta Biotherapeutics File Every Year?

Aleta Biotherapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAleta Biotherapeutics Applications FiledAleta Biotherapeutics Patents Granted
202232
2021142
2020141
2019151
2018362
20172
201632
2015
2014
2013
2012
2011

How many Aleta Biotherapeutics patents are Alive/Dead?

Worldwide Patents

Aleta Biotherapeutics Patent Portfolio

How Many Patents did Aleta Biotherapeutics File in Different Countries?

Aleta Biotherapeutics Worldwide Patent Filing

Countries in which Aleta Biotherapeutics Filed Patents

CountryPatents
United States Of America15
Japan10
Mexico10
Korea (South)9
Europe9
China9
Canada9
Israel9
Australia9
Hong Kong (S.A.R.)9
Brazil6
Chile4

Where are Research Centres of Aleta Biotherapeutics Patents Located?

R&D Centres of Aleta Biotherapeutics

10 Best Aleta Biotherapeutics Patents

CN108602872A is the most popular patent in the Aleta Biotherapeutics portfolio. It has received 15 citations so far from companies like Beijing Percans Oncology.

Below is the list of 10 most cited patents of Aleta Biotherapeutics:

Publication NumberCitation Count
CN108602872A15
WO2017075440A113
WO2018156802A111
US20180311374A18
WO2017075399A16
KR1020180081532A5
CN108473950A4
WO2018156791A14
US10508143B13
US20200306375A13

What are Aleta Biotherapeutics’ key innovation segments?

What Technologies are Covered by Aleta Biotherapeutics?

The chart below distributes patents filed by Aleta Biotherapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Aleta Biotherapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Aleta Biotherapeutics’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Aleta Biotherapeutics?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.